GENIL.E.IS Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: April 28, 2026
Report Source: 2025 Annual Report

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS. Stock Analysis GENIL.E.IS
Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS operates as a supplier of orphan drugs. The firm operates in the fields of manufacturing all kinds of pharmaceuticals for human use and health products, trading, import and export. Gen Ilac manufactures products used in the treatment of rare diseases and disorders in neurology, endocrinology, nephrology, oncology, hematology and pediatric branches. The firm has approximately 500 employees working in its production facilities on a closed area of 15,000 square meters, established on an area of approximately 43,000 square meters in Ankara ASO 2nd and 3rd Organized Industrial Zone. Entity has 5 offices abroad: Germany, Russia, Kazakhstan, Uzbekistan and Azerbaijan.
Read More Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS) Chart
Key Statistics of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
TRY9.30Volume
30.49MP/E Ratio (TTM)
51.1652 Week Range
Market Cap
36.15BAvg. Volume
32.99MDividend Yield
0.53%Financial Metrics & Statements of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS)
FAQ's for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS)
- According to Musaffa’s Shariah screening methodology, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL.E.IS) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.